Zolpidem tartrate sublingual

FDA Drug Profile — Zolpidem tartrate sublingual

Drug Details

Generic Name
Zolpidem tartrate sublingual
Brand Names
Zolpidem tartrate sublingual
Application Number
ANDA204229
Sponsor
ENDO USA, Inc.
NDC Codes
2
Dosage Forms
TABLET
Routes
SUBLINGUAL
Active Ingredients
ZOLPIDEM TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Zolpidem tartrate sublingual tablets are indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. Limitations of Use: Zolpidem tartrate sublingual tablets are not indicated for the treatment of middle-of-the-night insomnia when the patient has fewer than 4 hours of bedtime remaining before the planned time of waking. Zolpidem tartrate sublingual tablets are a GABA A agonist indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep Limitation of Use : Not indicated for the treatment of middle-of-the night awakening when the patient has fewer than 4 hours of bedtime remaining before the planned time of waking